Citation Impact
Citing Papers
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
2020 StandoutScience
Beta‐lactam plus macrolides or beta‐lactam alone for community‐acquired pneumonia: A systematic review and meta‐analysis
2016
Inference and control of the nosocomial transmission of methicillin-resistant Staphylococcus aureus
2018
Infective Endocarditis
2005 Standout
Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis
2012
Cochrane Database of Systematic Reviews
2003 Standout
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 Standout
Antimicrobial therapy for patients with severe sepsis and septic shock: An evidence-based review
2004
Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
2009 Standout
Risk Factors Associated with Potentially Antibiotic-Resistant Pathogens in Community-Acquired Pneumonia
2014
Prognosis and Outcomes of Patients With Community-Acquired Pneumonia
1996
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome
2004
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
2005 Standout
Streptococcus pneumoniaeProtein Vaccine Candidates: Properties, Activities and Animal Studies
2006
Severe community-acquired pneumonia in ICUs: Prospective validation of a prognostic score
1996
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
High Alcohol Intake as a Risk and Prognostic Factor for Community-Acquired Pneumonia
1995
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
A New Diagnostic Approach to the Patient with Severe Pneumonia
1989
Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review
2020
Early recognition ofStreptococcus pneumoniae in patients with community-acquired pneumonia
1996
Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia
2016
Diagnostic test for etiologic agents of community-acquired pneumonia
2004
Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors
1991
Predicting Death in Patients Hospitalized for Community-acquired Pneumonia
1991
Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.
1996
Diagnostic Fiberoptic Bronchoscopy in Patients with Community-acquired Pneumonia
1993
Treatment of Community-Acquired Pneumonia in Outpatients: Randomized Study of Clarithromycin Alone versus Clarithromycin and Cefuroxime
1999
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial
2004
An emergency department–based randomized trial of nonbronchoscopic bronchoalveolar lavage for early pathogen identification in severe community-acquired pneumonia
2001
Tissue‐Specific Contributions of Pneumococcal Virulence Factors to Pathogenesis
2004
Monotherapy May Be Suboptimal for Severe Bacteremic Pneumococcal Pneumonia
2001
Health Care–Associated Pneumonia Requiring Hospital Admission
2007
Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia
1996
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
1997 Standout
Time to Clinical Stability in Patients Hospitalized With Community-Acquired Pneumonia
1998
Extracellular targeting of choline‐binding proteins in Streptococcus pneumoniae by a zinc metalloprotease
2000 StandoutNobel
Clinical Efficacy of Pneumococcal Vaccine in the Elderly
1997
Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia
2005
Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis
2012
Clinical efficacy of anti-pneumococcal vaccination in patients with COPD
2005
The Burden of Respiratory Syncytial Virus Infection in Young Children
2009 Standout
Community-acquired pneumonia
2003
Diagnostic Value of Microscopic Examination of Gram-Stained Sputum and Sputum Cultures in Patients with Bacteremic Pneumococcal Pneumonia
2004
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
2011
Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
1998
Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP – Results from the German competence network CAPNETZ
2009
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
2003 Standout
Severe Sepsis and Septic Shock
2013 Standout
Community-Acquired Pneumonia Due to Gram-Negative Bacteria and Pseudomonas aeruginosa
2002
De-escalation therapy among bacteraemic patients with community-acquired pneumonia
2015
Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores
2006
Effect of Clonal and Serotype‐Specific Properties on the Invasive Capacity ofStreptococcus pneumoniae
2004
Impact of Initial Discordant Treatment With β-Lactam Antibiotics on Clinical Outcomes in Adults With Pneumococcal Pneumonia: A Systematic Review
2006
Processes and Outcomes of Care for Patients With Community-Acquired Pneumonia
1999
ASSESSING PROGNOSIS AND SELECTING AN INITIAL SITE OF CARE FOR ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA
1998
Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada
2004
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
2005
Individualizing Risk of Multidrug-Resistant Pathogens in Community-Onset Pneumonia
2015
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Bacterial Coinfection in Influenza
2013
Predicting Antimicrobial Resistance in Invasive Pneumococcal Infections
2005
Oral Moxifloxacin vs High-Dosage Amoxicillin in the Treatment of Mild-to-Moderate, Community-Acquired, Suspected Pneumococcal Pneumonia in Adults
2001
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review
2005
Validation of the 2001 American Thoracic Society criteria for severe community-acquired pneumonia
2004
Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis
2004 Standout
Once‐Daily Sparfloxacin Versus High‐Dosage Amoxicillin in the Treatment of Community‐Acquired, Suspected Pneumococcal Pneumonia in Adults
1998
Sialic acid-specific lectins: occurrence, specificity and function
2006
Treatment of Bacterial Meningitis
1997
Structure-based antigen design: a strategy for next generation vaccines
2008
Acyclovir and Prednisolone Treatment of Acute Infectious Mononucleosis: A Multicenter, Double-Blind, Placebo-Controlled Study
1996
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia
2009
Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978–1997
1999
Confronting the pneumococcus: a target shift or bullet change?
2000
Severity prediction rules in community acquired pneumonia: a validation study
2000
Aspiration Pneumonitis and Aspiration Pneumonia
2001 Standout
Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia
2004
Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia
2014
Ambulatory patients with community-acquired pneumonia: The frequency of atypical agents and clinical course
1996
Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia
2004
Infections in Patients with Diabetes Mellitus
1999 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
2009 Standout
Empirical Atypical Coverage for Inpatients With Community-Acquired Pneumonia
2005
Emergence of vancomycin tolerance in Streptococcus pneumoniae
1999 StandoutNatureNobel
Effectiveness of β lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis
2005
Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate Vaccine
2005
Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial
2001
β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis
2014
Severe Community-Acquired Pneumonia
1994
Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis
2016
A Potential Decline in Life Expectancy in the United States in the 21st Century
2005 Standout
Actual Causes of Death in the United States, 2000
2004 Standout
Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis
2011
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Bacteraemic pneumococcal pneumonia: A continuously evolving disease
1992
Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study
2005
Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia
2009
Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality*
2004
Factors associated with unknown aetiology in patients with community-acquired pneumonia
2002
Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage
2007
Macrolides and Mortality in Critically Ill Patients With Community-Acquired Pneumonia
2013
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Variant Mannose‐Binding Lectin Alleles Are Not Associated with Susceptibility to or Outcome of Invasive Pneumococcal Infection in Randomly Included Patients
2002
Immunological responses to pneumococcal vaccine in frail older people
2008
Improved Diagnosis of the Etiology of Community-Acquired Pneumonia with Real-Time Polymerase Chain Reaction
2005
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
Penicillin tolerance genes ofStreptococcus pneumoniae: the ABC‐type manganese permease complex Psa
1998 StandoutNobel
Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors.
1996
Guidelines for the management of adult lower respiratory tract infections
2005
Validation of the Infectious Diseases Society of America/American Thoratic Society Minor Criteria for Intensive Care Unit Admission in Community-Acquired Pneumonia Patients Without Major Criteria or Contraindications to Intensive Care Unit Care
2011
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
2012
Frailty in elderly people
2013 Standout
Do Guidelines for Community-Acquired Pneumonia Improve the Cost-Effectiveness of Hospital Care?
2001
Current pharmacotherapy of pneumococcal meningitis
2002
Epidemiology of community-acquired pneumonia in adults: a population-based study
2000
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
2004
Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b
1999
Bacteremic and Nonbacteremic Pneumococcal Pneumonia A Prospective Study
2000
A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit
1995
COPD exacerbations: definitions and classifications
2003
Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality
2016
Community-Acquired Pneumonia
2014
Epstein–Barr Virus Infection
2000 Standout
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Etiology of Community-Acquired Pneumonia:
1999
Severe Community-acquired Pneumonia
2002
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Antimicrobial Treatment Failures in Patients with Community-acquired Pneumonia
2000
Medical Section pf the American Lung Association: Guidelines for the Initial Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antimicrobial Therapy
1993
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Etiology of Severe Pneumonia in the Very Elderly
2001
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Systematic Review and Meta-analysis of the Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia in Adults
2018
Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review
2001
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
2003 Standout
Antibiotics for community-acquired pneumonia in adult outpatients
2014
Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management
1993
Healthcare‐associated pneumonia: A US disease or relevant to the A sia P acific, too?
2013
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
2000
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
2009 Standout
Insights into the Interaction between Influenza Virus and Pneumococcus
2006
Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
2003
Pneumococcal Virulence Factors: Structure and Function
2001
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
2015
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
2000
The gut microbiota as an environmental factor that regulates fat storage
2004 Standout
Medical Outcomes and Antimicrobial Costs With the Use of the American Thoracic Society Guidelines for Outpatients With Community-Acquired Pneumonia
1997
Detection of Streptococcus pneumoniae Antigen by a Rapid Immunochromatographic Assay in Urine Samples
2001
High-Dose Levofloxacin in Community-Acquired Pneumonia
2012
β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia
2014
Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases.
1997
Imaging the glycome
2008 StandoutNobel
Do Pulmonary Radiographic Findings at Presentation Predict Mortality in Patients With Community-Acquired Pneumonia?
1996
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Identification of Invasive Serotype 1 Pneumococcal Isolates That Express Nonhemolytic Pneumolysin
2006
Inactivation of CMP- N -acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution
2002 StandoutNobel
Comparison of Two Urinary Antigen Tests for Establishment of Pneumococcal Etiology of Adult Community-Acquired Pneumonia
2004
Exame do escarro no manejo clínico dos pacientes com pneumonia adquirida na comunidade
2008
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
2020 Standout
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs
2005 Standout
Testing Strategies in the Initial Management of Patients with Community-Acquired Pneumonia
2003
Duration of Antibiotic Treatment in Community-Acquired Pneumonia
2016
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
2003
The Impact of Alcohol-Related Diagnoses on Pneumonia Outcomes
1997
Chemical Diversity in the Sialic Acids and Related α-Keto Acids: An Evolutionary Perspective
2002
Insertion Sequence 1515 in the ply Gene of a Type 1 Clinical Isolate of Streptococcus pneumoniae Abolishes Pneumolysin Expression
2007 StandoutNobel
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020 Standout
Pneumococcal Vaccine After 15 Years of Use
1994
Works of Åke Örtqvist being referenced
Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differences
2006
Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization
1990
An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical Outcome
2003
Contribution of novel choline‐binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae
1997
Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective
1995
Comparison of three methods for detection of pneumococcal antigen in sputum of patients with community-acquired pneumonia
1989
Guidelines for the management of adult lower respiratory tract infections - Full version
2011
Limited Value of Routine Microbiological Diagnostics in Patients Hospitalized for Community-acquired Pneumonia
2002
Association of Serotypes of Streptococcus pneumoniae with Disease Severity and Outcome in Adults: An International Study
2007
Clonal and Capsular Types Decide Whether Pneumococci Will Act as a Primary or Opportunistic Pathogen
2006
Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up
2003
Deaths in Bacteremic Pneumococcal Pneumonia
1993
Oral Empiric Treatment of Community-Acquired Pneumonia
1996
Prospective Study of Prognostic Factors in Community‐Acquired Bacteremic Pneumococcal Disease in 5 Countries
2000
Guidelines for the management of adult lower respiratory tract infections - Summary
2011
Cost-Effectiveness of Pneumococcal Vaccination of Older People: A Study in 5 Western European Countries
2000
Clinical Isolates of Streptococcus pneumoniae That Exhibit Tolerance of Vancomycin
2001
Diagnostic Fiberoptic Bronchoscopy and Protected Brush Culture in Patients with Community-Acquired Pneumonia
1990
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
2004
Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study
2001
Gram-negative bacteria from patients seeking medical advice in Stockholm after the tsunami catastrophe
2006
Addition of a macrolide to a ß-lactam in bacteremic pneumococcal pneumonia
2006
Molecular Epidemiology ofStreptococcus pneumoniaeCausing Invasive Disease in 5 Countries
2000
Diagnosis of Bacteremic Pneumococcal Pneumonia by Amplification of Pneumolysin Gene Fragment in Serum
1995
Dynamics of Penicillin‐Susceptible Clones in Invasive Pneumococcal Disease
2001
Bacteremic Pneumococcal Pneumonia in Sweden: Clinical Course and Outcome and Comparison with Non-bacteremic Pneumococcal and Mycoplasmal Pneumonias
1988
Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia
2013
MENINGITIS
1993
Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care
2009
Sparfloxacin as alternative treatment to standard therapy for community-acquired bacteremic pneumococcal pneumonia
1998
Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults—Swedish Society of Infectious Diseases 2012
2012
Changes in Serotype Distribution may Hamper Efficacy of Pneumococcal Conjugate Vaccines in Children
2001
Streptococcus pneumoniae: Epidemiology, Risk Factors, and Clinical Features
2005
Bacteremic Pneumococcal Pneumonia in Stockholm, Sweden, in 1984
1988
Imported Methicillin-ResistantStaphylococcus aureus, Sweden
2010
Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development
2007
Management of Patients with Community-acquired Pneumonia Treated in Hospital in Sweden
2002
Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia
2004
Prognosis in Community-Acquired Pneumonia Requiring Treatment in Hospital: Importance of Predisposing and Complicating Factors, and of Diagnostic Procedures
1989
Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area
2007
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies
2007
Acyclovir treatment in infectious mononucleosis: A clinical and virological study
1987
[Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
2008
Severe Community-acquired Pneumonia: Factors Influencing Need of Intensive Care Treatment and Prognosis
1985
Initial investigation and treatment of the patient with severe community-acquired pneumonia.
1994